# The GigaCT: Advancing Photon-Counting CT for Next-Generation Spectral Imaging - Varex Imaging
Canonical URL: https://biopharmsignal.com/news/VREX/the-gigact-advancing-photon-counting-ct-for-next-generation-spectral-imaging-var-753f47a9
Ticker: VREX
Company: Varex Imaging
Source: Varex Imaging
Published: 2026-07-08 16:03 EST
Original Source URL: https://www.vareximaging.com/news/
## Summary

Varex Imaging, in collaboration with the Technical University of Munich (TUM) and Schleifring GmbH, has introduced the GigaCT, a next-generation photon-counting CT (PCCT) research system designed to overcome current limitations in spectral imaging. The prototype features a high-speed data architecture and advanced detector technology, enabling improved spatial resolution and material differentiation compared to conventional CT […]

## Article Body
May 18, 2026

Varex Imaging, in collaboration with the Technical University of Munich (TUM) and Schleifring GmbH, has introduced the GigaCT, a next-generation photon-counting CT (PCCT) research system designed to overcome current limitations in spectral imaging. The prototype features a high-speed data architecture and advanced detector technology, enabling improved spatial resolution and material differentiation compared to conventional CT […]

Varex Imaging, in collaboration with the Technical University of Munich (TUM) and Schleifring GmbH, has introduced the GigaCT, a next-generation photon-counting CT (PCCT) research system designed to overcome current limitations in spectral imaging. The prototype features a high-speed data architecture and advanced detector technology, enabling improved spatial resolution and material differentiation compared to conventional CT systems. Early results demonstrate strong potential for applications in clinical research areas such as cardiovascular imaging, oncology, and musculoskeletal studies. As development continues, GigaCT is expected to support new advances in spectral CT imaging, including multi-contrast detection and lower-dose scanning.

Read the full white paper here:

Giga CT White Paper (2)

06

Articles
## Recent Company News
- 2026-07-09 15:15 EST — [VAREX TO PRESENT AT THE JEFFERIES GLOBAL HEALTHCARE CONFERENCE - Varex Imaging](https://biopharmsignal.com/news/VREX/varex-to-present-at-the-jefferies-global-healthcare-conference-varex-imaging-7485a79a) — Source: Varex Imaging
- 2026-07-08 16:03 EST — [The GigaCT: Advancing Photon-Counting CT for Next-Generation Spectral Imaging - Varex Imaging](https://biopharmsignal.com/news/VREX/the-gigact-advancing-photon-counting-ct-for-next-generation-spectral-imaging-var-753f47a9) — Source: Varex Imaging
- 2026-07-07 17:53 EST — [White Paper: Pyxis™ Photon-Counting CT Detection Platform – Simplifying the Integration of Photon-Counting Computed Tomography - Varex Imaging](https://biopharmsignal.com/news/VREX/white-paper-pyxis-photon-counting-ct-detection-platform-simplifying-the-integrat-9b2cc7b7) — Source: Varex Imaging
- 2026-07-07 17:49 EST — [Replacing Mechanical Motion in X-ray Imaging: Varex Multi-Beam X-ray (MBX) Technology - Varex Imaging](https://biopharmsignal.com/news/VREX/replacing-mechanical-motion-in-x-ray-imaging-varex-multi-beam-x-ray-mbx-technolo-15a26bbf) — Source: Varex Imaging
- 2026-06-29 18:05 EST — [Tackling CT artifacts in multi-material parts: TrueSpectrum™ at ECNDT 2026 - Varex Imaging](https://biopharmsignal.com/news/VREX/tackling-ct-artifacts-in-multi-material-parts-truespectrum-at-ecndt-2026-varex-i-b14701de) — Source: Varex Imaging
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)
- 2026-07-20 13:00 EST — ENLV — [Enlivex Treasury Portfolio Update: NAV Per Ordinary Share $66.16; Total Treasury Holdings Valued at Approximately $1.1 Billion](https://biopharmsignal.com/news/ENLV/enlivex-treasury-portfolio-update-nav-per-ordinary-share-66-16-total-treasury-ho-9d036ef9)